ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc (0LIF)

64.79
0.00
( 0.00% )
Updated: 20:00:00

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 540.63M490.75M719.56M1.14B1.76B1.52B1.55B1.49B
Total Current Assets 401.7M269.58M522.37M851.02M1.3B856.6M883.9M732.18M
Cash and Equivalents 161.12M100.49M113.43M433.58M713.53M307.58M132.94M213.58M
Total Non-Current Assets 473.97M383.45M608.91M653.76M1.15B922.56M352.49M275.41M
Total Liabilities 66.65M107.3M110.65M481.73M605.18M599.84M1.19B1.22B
Total Current Liabilities 60.26M71.01M74.73M103.3M189.61M181.37M261.21M280.44M
Total Non-Current Liabilities 6.39M36.29M35.93M378.43M751.94M770.66M1.81B1.8B
Total Equity 473.97M383.45M608.91M653.76M1.15B922.56M352.49M275.41M
Common Equity 41k44k51k58k67k69k70k82k
Retained Earnings -530.53M-832.67M-1.03B-1.43B-1.62B-2.07B-2.78B-3.39B